|Bid||0.2061 x 1400|
|Ask||0.2078 x 1000|
|Day's range||0.2010 - 0.2200|
|52-week range||0.2000 - 4.3600|
|Beta (5Y monthly)||1.38|
|PE ratio (TTM)||N/A|
|Earnings date||10 May 2023 - 15 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.40|
Evelo Biosciences, Inc. (EVLO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
The heavy selling pressure might have exhausted for Evelo Biosciences, Inc. (EVLO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...